General Anesthesia Increased the Risk of Atrial Fibrillation and Acute Kidney Injury in Transcatheter Aortic Valve Replacement
Focus on TAVR Anesthesia
DOI:
https://doi.org/10.1532/hsf.3361Keywords:
anesthesia, transcatheter aortic valve replacement, acute kidney injury, paravalvular leakage, atrial fibrillation, outcomesAbstract
Purpose: To examine key impacts of anesthesia on new-onset atrial fibrillation (AF) and acute kidney injury (AKI) in transcatheter aortic valve replacement (TAVR).
Methods: All consecutive patients who underwent transfemoral, transapical, and transaortic TAVR in Fuwai Hospital from 2012 to 2018 were retrospectively analyzed and dichotomized into 2 groups: TAVR under conscious sedation (CS) and under general anesthesia (GA). The primary endpoint was a composite of all-cause mortality, stroke, AF, permanent pacemaker implantation, myocardial infarction, heart failure, high-grade atrioventricular block, and AKI at 1 year. Binary logistic regression and adjusted multilevel logistic regression were performed to analyze the predictors of AF and AKI.
Results: A total of 107 patients were under CS and 66 patients under GA. No significant difference was observed in the composite endpoint (51.5% vs. 41.2%, GA vs. CS, P = .182) and ≥ mild paravalvular leakage (36.4% vs. 31.4%, GA vs. CS, P = .589) at 1 year. However, the GA group had a significantly higher rate of intensive care unit (ICU) admission (84.8% vs. 6.5%, P < .001), AKI (28.8% vs. 14.0%, P = .018), new-onset AF (15.2% vs. 5.5% at 1 year, P = .036). Multivariable analysis revealed GA to be the significant predictor of new-onset AF (odds ratio 3.237, 95% confidence interval 1.059 to 9.894, P = .039) and AKI (odds ratio 2.517, 95% confidence interval 1.013 to 6.250, P = .047).
Conclusion: GA was associated with higher rates of ICU admission, postoperative AKI, and new-onset AF. The results may provide new evidence that CS challenges universal GA.
References
Aalaei-Andabili SH, Pourafshar N, Bavry AA, et al. Acute kidney injury after transcatheter aortic valve replacement. J Card Surg 2016;31:416-422.
Ahlsson A, Fengsrud E, Bodin L, Englund A. Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality. Eur J Cardiothorac Surg 2010;37:1353-1359.
Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996;94:390-397.
Attard S, Buttigieg J, Galea S, et al. The incidence, predictors, and prognosis of acute kidney injury after transcatheter aortic valve implantation. Clin Nephrol 2018;90:373-379.
Attizzani GF, Alkhalil A, Padaliya B, et al. Comparison of outcomes of transfemoral transcatheter aortic valve implantation using a minimally invasive versus conventional strategy. Am J Cardiol 2015;116:1731-1736.
Attizzani GF, Patel SM, Dangas GD, et al. Comparison of local versus general anesthesia following transfemoral transcatheter self-expanding aortic valve implantation (from the transcatheter valve therapeutics registry). Am J Cardiol 2019;123:419-425.
Bagur R, Rodes-Cabau J, Doyle D, et al. Usefulness of tee as the primary imaging technique to guide transcatheter transapical aortic valve implantation. JACC Cardiovasc Imaging 2011;4:115-124.
Bainbridge D, Martin J, Arango M et al. Perioperative and anaesthetic-related mortality in developed and developing countries: A systematic review and meta-analysis. Lancet 2012;380:1075-1081.
Bartel T, Bonaros N, Muller L, et al. Intracardiac echocardiography: A new guiding tool for transcatheter aortic valve replacement. J Am Soc Echocardiogr 2011;24:966-975.
Ben-Dor I, Looser PM, Maluenda G, et al. Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation. Cardiovasc Revasc Med 2012;13:207-210.
Butala NM, Chung M, Secemsky EA, et al. Conscious sedation versus general anesthesia for transcatheter aortic valve replacement: Variation in practice and outcomes. JACC Cardiovasc Interv 2020;13:1277-1287.
Cocchieri R, Petzina R, Romano M, et al. Outcomes after transaortic transcatheter aortic valve implantation: Long-term findings from the European ROUTE†. Eur J Cardiothorac Surg 2019;55:737-743.
Durand E, Borz B, Godin M et al. Transfemoral aortic valve replacement with the Edwards Sapien and Edwards Sapien XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: Feasibility and 30-day outcomes. JACC Cardiovasc Interv 2012;5:461-467.
Helgadottir S, Sigurdsson MI, Ingvarsdottir IL, et al. Atrial fibrillation following cardiac surgery: Risk analysis and long-term survival. J Cardiothorac Surg 2012;7:87.
Hellhammer K, Piayda K, Afzal S et al. The latest evolution of the Medtronic CoreValve system in the era of transcatheter aortic valve replacement: Matched comparison of the Evolut PRO and Evolut R. JACC Cardiovasc Interv 2018;11:2314-2322.
Hyman MC, Vemulapalli S, Szeto WY et al. Conscious sedation versus general anesthesia for transcatheter aortic valve replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology transcatheter valve therapy registry. Circulation 2017;136:2132-2140.
Kadakia MB, Silvestry FE, Herrmann HC. Intracardiac echocardiography-guided transcatheter aortic valve replacement. Catheter Cardiovasc Interv 2015;85:497-501.
Kappetein AP, Head SJ, Genereux P et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document (varc-2). Eur J Cardiothorac Surg 2012;42:S45-S60.
Kiramijyan S, Ben-Dor I, Koifman E, et al. Comparison of clinical outcomes with the utilization of monitored anesthesia care vs. general anesthesia in patients undergoing transcatheter aortic valve replacement. Cardiovasc Revasc Med 2016;17:384-390.
Konigstein M, Ben-Shoshan J, Zahler D et al. Outcome of patients undergoing TAVR with and without the attendance of an anesthesiologist. Int J Cardiol 2017;241:124-127.
Kumar N, Garg N. Acute kidney injury after aortic valve replacement in a nationally representative cohort in the USA. Nephrol Dial Transplant 2019;34:295-300.
Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-1607.
Leon MB, Smith CR, Mack MJ et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609-1620.
Maier A, Hammerich B, Humburger F, et al. A logistic regression analysis comparing minimalistic approach and intubation anaesthesia in patients undergoing transfemoral transcatheter aortic valve replacement. PLoS One 2020;15:e0227345.
Manoharan G, Van Mieghem NM, Windecker S, et al. 1-year outcomes with the evolut r self-expanding transcatheter aortic valve: From the international forward study. JACC Cardiovasc Interv 2018;11:2326-2334.
Marcantuono R, Gutsche J, Burke-Julien M, et al. Rationale, development, implementation, and initial results of a fast track protocol for transfemoral transcatheter aortic valve replacement (TAVR). Catheter Cardiovasc Interv 2015;85:648-654.
Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720-1729.
Mosleh W, Mather JF, Amer MR, et al. Propensity matched analysis comparing conscious sedation versus general anesthesia in transcatheter aortic valve implantation. Am J Cardiol 2019;124:70-77.
Nuis RJ, Rodes-Cabau J, Sinning JM, et al. Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation. Circ Cardiovasc Interv 2012;5:680-688.
Oguri A, Yamamoto M, Mouillet G, et al. Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia: Subanalysis of the French Aortic National Corevalve and Edwards 2 registry. Circ Cardiovasc Interv 2014;7:602-610.
Saia F, Ciuca C, Taglieri N, et al. Acute kidney injury following transcatheter aortic valve implantation: Incidence, predictors and clinical outcome. Int J Cardiol 2013;168:1034-1040.
Thiele H, Kurz T, Feistritzer HJ, et al. General versus local anesthesia with conscious sedation in transcatheter aortic valve implantation: The randomized SOLVE-TAVI trial. Circulation 2020;142:1437-1447.
Van Mieghem NM, Tchetche D, Chieffo A, et al. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. Am J Cardiol 2012;110:1361-1367.
Villareal RP, Hariharan R, Liu BC, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 2004;43:742-748.
Yagasaki H, Goto Y, Mori Y, Noda T. Transcatheter aortic valve replacement with intracardiac echocardiography from the right internal jugular vein. Cardiovasc Diagn Ther 2018;8:525-529.
Zaouter C, Smaili S, Leroux L, et al. Transcatheter aortic valve implantation: General anesthesia using transesophageal echocardiography does not decrease the incidence of paravalvular leaks compared to sedation alone. Ann Card Anaesth 2018;21:277-284.
